Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis

Archainnova Biotechnologies aims to create an innovative, long term, and economical solution for the treatment of osteoarthritis. To do so we will utilize microfluidic technology to encapsulate mesenchymal stem cells in Polyethylene Glycol (PEG) gel to enable industrial implementation of stem cell therapy. Our process will use mesenchymal stem cells purified from bone marrow to stimulate permanent regrowth of degrading cartilage. The stem cells utilized in this process are immuno-privileged, which allows for a large scale patient to patient stem cell implementation. This creates a streamlined distribution network and a more economical treatment option.